158 related articles for article (PubMed ID: 31419286)
1. Combination of Azithromycin and Gentamicin for Efficient Treatment of Pseudomonas aeruginosa Infections.
Ren H; Liu Y; Zhou J; Long Y; Liu C; Xia B; Shi J; Fan Z; Liang Y; Chen S; Xu J; Wang P; Zhang Y; Zhu G; Liu H; Jin Y; Bai F; Cheng Z; Jin S; Wu W
J Infect Dis; 2019 Oct; 220(10):1667-1678. PubMed ID: 31419286
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
Thomsen K; Christophersen L; Lerche CJ; Holmgaard DB; Calum H; Høiby N; Moser C
Int J Antimicrob Agents; 2021 Jan; 57(1):106213. PubMed ID: 33256950
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
4. Increased therapeutic efficacy of combination of azithromycin and ceftazidime on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
Wang X; Cai Y; Xing H; Wu W; Wang G; Li L; Chen J
BMC Microbiol; 2016 Jun; 16(1):124. PubMed ID: 27341798
[TBL] [Abstract][Full Text] [Related]
5. Natural Derived Surfactant Preparation As a Carrier of Polymyxin E for Treatment of Pseudomonas aeruginosa Pneumonia in a Near-Term Rabbit Model.
Basabe-Burgos O; Zebialowicz J; Stichtenoth G; Curstedt T; Bergman P; Johansson J; Rising A
J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):110-118. PubMed ID: 30339061
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Pseudomonas aeruginosa quorum sensing by subinhibitory concentrations of curcumin with gentamicin and azithromycin.
Bahari S; Zeighami H; Mirshahabi H; Roudashti S; Haghi F
J Glob Antimicrob Resist; 2017 Sep; 10():21-28. PubMed ID: 28591665
[TBL] [Abstract][Full Text] [Related]
7. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873
[TBL] [Abstract][Full Text] [Related]
8. PA5470 Counteracts Antimicrobial Effect of Azithromycin by Releasing Stalled Ribosome in Pseudomonas aeruginosa.
Shi J; Liu Y; Zhang Y; Jin Y; Bai F; Cheng Z; Jin S; Wu W
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203495
[No Abstract] [Full Text] [Related]
9. Attenuation of Pseudomonas aeruginosa biofilm formation by Vitexin: A combinatorial study with azithromycin and gentamicin.
Das MC; Sandhu P; Gupta P; Rudrapaul P; De UC; Tribedi P; Akhter Y; Bhattacharjee S
Sci Rep; 2016 Mar; 6():23347. PubMed ID: 27000525
[TBL] [Abstract][Full Text] [Related]
10. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms.
Lebeaux D; Chauhan A; Létoffé S; Fischer F; de Reuse H; Beloin C; Ghigo JM
J Infect Dis; 2014 Nov; 210(9):1357-66. PubMed ID: 24837402
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model.
Nicolau DP; Banevicius MA; Nightingale CH; Quintiliani R
Antimicrob Agents Chemother; 1999 Dec; 43(12):3033-5. PubMed ID: 10582906
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin Modulates 3',5'-cyclic Diguanylic Acid Signaling in Pseudomonas aeruginosa.
Kimura S; Mori N; Kai T; Ishii Y; Yamaguchi K; Tateda K
J Infect Chemother; 2017 Aug; 23(8):550-555. PubMed ID: 28579350
[TBL] [Abstract][Full Text] [Related]
13. Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae.
Ren H; Zhang J; Zhou J; Xu C; Fan Z; Pan X; Li S; Liang Y; Chen S; Xu J; Wang P; Zhang Y; Zhu G; Liu H; Jin Y; Bai F; Cheng Z; Pletzer D; Wu W
J Antibiot (Tokyo); 2021 Aug; 74(8):528-537. PubMed ID: 34050325
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
Li Y; Huang J; Li L; Liu L
Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
[TBL] [Abstract][Full Text] [Related]
15. The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent.
Banin E; Lozinski A; Brady KM; Berenshtein E; Butterfield PW; Moshe M; Chevion M; Greenberg EP; Banin E
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16761-6. PubMed ID: 18931304
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Pexiganan Combination with Tigecycline in a Mouse Model of Pseudomonas aeruginosa Sepsis.
Cirioni O; Simonetti O; Morroni G; Brescini L; Kamysz W; Kamysz E; Orlando F; Pierpaoli E; Caffarini M; Orciani M; Agostinelli C; Offidani A; Provinciali M; Giacometti A
Curr Top Med Chem; 2018; 18(24):2127-2132. PubMed ID: 30569865
[TBL] [Abstract][Full Text] [Related]
17. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
Hoffmann N; Lee B; Hentzer M; Rasmussen TB; Song Z; Johansen HK; Givskov M; Høiby N
Antimicrob Agents Chemother; 2007 Oct; 51(10):3677-87. PubMed ID: 17620382
[TBL] [Abstract][Full Text] [Related]
19. Increased tolerance to commonly used antibiotics in a
Okurowska K; Monk PN; Karunakaran E
Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739119
[No Abstract] [Full Text] [Related]
20. A peptide based on homologous sequences of the β-barrel assembly machinery component BamD potentiates antibiotic susceptibility of Pseudomonas aeruginosa.
Mori N; Ishii Y; Tateda K; Kimura S; Kouyama Y; Inoko H; Mitsunaga S; Yamaguchi K; Yoshihara E
J Antimicrob Chemother; 2012 Sep; 67(9):2173-81. PubMed ID: 22628248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]